[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100539600":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":32,"centralContacts":33,"locations":42,"responsibleParty":55,"collaborators":57,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":32,"eligibilityCriteria":74,"healthyVolunteers":70,"sex":75,"minAge":76,"maxAge":32,"enrollmentInfo":77,"targetDuration":32,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":32,"overallStatus":45,"whyStopped":32,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"NEUROPHET","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Optimized transcranial Direct Current Stimulation","EXPERIMENTAL","Patients receive optimized stimulation obtained from an individualized T1 MRI-based simulation of transcranial direct current stimulation for 30 minutes, once a day for 4 weeks, for a total of 20 sessions.",[13],"Device: Optimized transcranial Direct Current Stimulation",{"label":15,"type":16,"description":17,"interventionNames":18},"Sham transcranial Direct Current Stimulation","SHAM_COMPARATOR","Patients receive sham stimulation for 30 minutes, once a day for 4 weeks, for a total of 20 sessions.",[19],"Device: Sham transcranial Direct Current Stimulation",[21,28],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","transcranial Direct Current Stimulation 2mA for 30 min; The anode electrode will be located over the contralesional representation of the motor cortex swallowing area, while the cathode electrode will be positioned on the ipsilesional side",[9],[26,27],"NEUROPHET tES LAB","NEUROPHET innk01-DW",{"type":22,"name":15,"description":29,"armGroupLabels":30,"otherNames":31},"transcranial Direct Current sham Stimulation for 30 min; The anode electrode will be located over the contralesional representation of the motor cortex swallowing area, while the cathode electrode will be positioned on the ipsilesional side",[15],[26,27],null,[34,39],{"name":35,"role":36,"phone":37,"phoneExt":32,"email":38},"TaeYeong Kim","CONTACT","827051678882","ty.kim@neurophet.com",{"name":40,"role":36,"phone":32,"phoneExt":32,"email":41},"Seungeun Lee","selee@neurophet.com",[43],{"facility":44,"status":45,"city":46,"state":32,"zip":47,"country":48,"countryCode":32,"cosmosGeoPoint":49,"geoPoint":54,"contacts":32},"The Catholic University of Korea, Bucheon St. Mary's Hospital","RECRUITING","Bucheon-si","14647","South Korea",{"type":50,"coordinates":51},"Point",[52,53],126.78306,37.49889,{"lat":53,"lon":52},{"type":56,"investigatorFullName":32,"investigatorTitle":32,"investigatorAffiliation":32,"oldNameTitle":32,"oldOrganization":32},"SPONSOR",[58,61,63,66],{"name":59,"class":60},"Bucheon St. Mary's Hospital","OTHER",{"name":62,"class":60},"Saint Vincent's Hospital, Korea",{"name":64,"class":65},"National Traffic Injury Rehabilitation Hospital","UNKNOWN",{"name":67,"class":60},"Pusan National University Yangsan Hospital","100539600","clinical-trial-on-the-safety-and-efficacy-of-optimized-transcranial-direct-current-stimulation-for-the-swallowing-function-in-patients-with-post-stroke-dysphagia-100539600",false,"NCT06305949","Clinical Trial on the Safety and Efficacy of Optimized Transcranial Direct Current Stimulation for the Swallowing Function in Patients With Post-Stroke Dysphagia","A Multi-center, Randomized, Double-blind, Pilot Study to Evaluate the Safety and Efficacy of Optimized Transcranial Direct Current Stimulation for the Transitory Improvement of Swallowing Function in Patients With Post-stroke Dysphagia","Inclusion Criteria:\n\n* men and women \\>19 years old\n* patients with stroke confirmed by neuroimaging\n* first-time stroke patients\n* patients in subacute or chronic phases of stroke with 3 weeks or more after onset\n* stroke patients with confirmed dysphagia through Videofluoroscopic Swallowing Study (VFSS).\n\nExclusion Criteria:\n\n* patients with recurrent stoke, traumatic brain injury, spine cord injury, and degenerative brain disease, such as Parkinson's disease, etc.\n* patients with deteriorated cognitive function unable to perform the clinical trial as instructed\n* patients with evidence of delirium, confusion, or other impairment of consciousness\n* patients with uncontrolled medical disease or surgical conditions\n* patients ineligible for Transcranial direct current stimulation (due to scalp condition, metallic material at the electrode attachment area, presence of a pacemaker or cochlear implant)\n* patients with previous experience within the last year using a stimulation device similar to the one use in this clinical trial or who have participated in related clinical trials\n* patients with severe neurologic disorder with concomitant major psychiatric disorder such as major depressive disorder and dementia\n* patients with history of uncontrolled epilepsy within 6 months\n* patients with medical contraindications for neuroimaging test, such as MRI;\n* patients who are taken contraindicated medications or require medication changes during the trial period that could influence cognitive\u002Fmotor function changes via brain activation changes\n* patients who are pregnant, breastfeeding, or planning pregnancy during the trial period\n* patients considered medically ineligible for participation in the present trial beyond the criteria listened above.","ALL","19 Years",{"count":78,"type":79},30,"ESTIMATED","INTERVENTIONAL",[82],"NA","The goal of this clinical trial is to evaluate whether the application of optimized transcranial direct current stimulation is more effective compared to sham stimulation for temporary improvement of swallowing function in patients with post-stroke dysphagia.",[85],"Deglutition Disorders","2026-04-07",{"date":88,"type":89},"2026-04-09","ACTUAL",{"date":91,"type":89},"2024-04-22",{"date":93,"type":79},"2026-06-30",{"name":5,"class":6},1]